GHC Reflects on its Own First 100 Days
In global health, we know benchmarks matter. They’re the difference between whether a child reaches his or her 5th birthday or dies of a vaccine-preventable illness. They signal how a health system would respond to the next pandemic or humanitarian crisis. What gets measured gets done, and saves lives. That’s why GHC has been paying attention these first 100 days of 2017. We looked at what we’ve done to serve our members, and opportunities to make the greatest impact. Thank you to all of the global health advocates who have joined us so far. Read more.
GHC Hosts Discussion on U.S. Leadership and Engagement at WHA
On April 25, GHC convened various stakeholders for a critical dialogue on the U.S. government’s priorities at the Seventieth World Health Assembly (WHA70). The one-hour webinar, which attracted over 60 participants from the non-profit, academia, international development, and government sectors, was the second in a series of WHA Policy Scrums organized by GHC in preparation for WHA70. We were honored to have special guest speakers with strong government backgrounds and experience at WHA participate in our webinar and share their insights on the best way for civil society to engage at WHA70. You can view brief notes or watch the full webinar recording that provide a recap of this important conversation. Please join us for our final WHA Policy Scrum and New Delegate Webinar on May 9. Registration details.
A New Malaria Vaccine Implementation Program in Africa
The World Health Organization Regional Office for Africa (WHO/AFRO) announced that Ghana, Kenya, and Malawi will participate in the WHO-coordinated pilot implementation of the RTS,S malaria vaccine. RTS,S was developed to protect young children from infection by Plasmodium falciparum, the deadliest of the malaria parasites affecting humans. It is the first malaria vaccine candidate to be recommended for pilot implementation by WHO, and the first to receive a positive opinion from a stringent regulatory authority, the European Medicines Agency (EMA). The Malaria Vaccine Implementation Program (MVIP) is being coordinated and led by WHO in close collaboration with Ministries of Health in the participating countries and a range of in-country and international partners. Learn more.
Call for Nongovernmental Organizations to apply for Consultative Status with the United Nations
The United Nations invites nongovernmental organizations (NGOs) to apply for consultative status with its Economic and Social Council (ECOSOC) if they wish to be considered by the NGO Committee in 2018. NGOs that are accredited with ECOSOC can participate in a number of events including, but not limited to, regular sessions of ECOSOC, its functional commissions, and its other subsidiary bodies. Consultative relationships may be established with international, regional, sub-regional, and national non-governmental, non-profit public, or voluntary organizations. Those interested should submit their application and required documents by June 1. View the call for applications.
Global Resolve to End Neglected Tropical Diseases
The NTD Summit 2017, held between April 19 – 22, drew attention to the unprecedented progress and milestones that have been reached in efforts to control, eliminate, and eradicate neglected tropical diseases (NTDs) over the last five years. For several decades, development of new drugs and vaccines to target the most debilitating NTDs, categorically described as diseases of poverty, stalled because there was simply no business incentive to do so. Since the signing of the London Declaration on NTDs in 2012, pharmaceutical companies, academic institutions, NGOs, and other partners have joined forces to bring treatment to millions of people afflicted by NTDs. NTDs kill, disable, disfigure, stigmatize, and cost developing economies billions of dollars every year in lost productivity. Progress in NTD eradication has been touted as a remarkable display of how U.S. foreign assistance works to eliminate obstacles to development. Read more.
Registration is Now Open for the Women Leaders in Global Health Conference
Women in Global Health (WGH) is a movement of dynamic professionals around the world, of all genders and backgrounds, working within many different areas of global health looking to achieve gender equality in global health leadership. WGH believes that diverse, gender-balanced leadership is key for achieving the sustainable development goals (SDGs), improving health and well-being, and are working to give all genders an equitable voice in the global health arena. WGH is pleased to partner with Stanford University’s Center for Innovation in Global Health to present the Women Leaders in Global Health Conference this October 12. Registration is now open for this inaugural event. The conference builds on the global movement to press for gender equity in global health leadership by celebrating great works of emerging and established women in the field and cultivating the next generation of women leaders. More details.